V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20163629 | 20063029 | 1.64 | 119.9 | Palliative (P) | 2020-01-05 | 2020-01-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100997081 |
| 20163637 | 20063030 | 1.78 | 67 | Neo-adjuvant (N) | 2020-01-06 | 2020-01-26 | ECX | N | N | ECX | 101579944 |
| 20163639 | 20063031 | 1.75 | 90.3 | Curative (C) | 2018-03-08 | 2018-03-08 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100959379 |
| 20163648 | 20063032 | 1.85 | 116 | null | 2017-11-19 | 2017-12-03 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100039653 |
| 20163655 | 20063033 | 1.86 | 58.5 | Palliative (P) | 2018-10-05 | 2018-10-05 | ECX | 2 | N | ECX | 101680812 |
| 20163658 | 20063034 | 1.81 | 63.2 | Adjuvant (A) | 2019-10-07 | 2019-11-01 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100692792 |
| 20163660 | 20063035 | 1.57 | 75.6 | Neo-adjuvant (N) | 2019-04-14 | 2019-04-26 | ECX | N | N | ECX | 101489366 |
| 20163662 | 20063036 | 1.69 | 63.3 | Palliative (P) | 2019-09-24 | 2019-10-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100519497 |
| 20163666 | 20063037 | 1.71 | 69.5 | Curative (C) | 2018-03-18 | 2018-04-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101791846 |
| 20163668 | 20063038 | null | 69.4 | Palliative (P) | 2017-03-15 | 2017-04-09 | ECX | N | N | ECX | 100461171 |
| 20163677 | 20063039 | 1.77 | 92.6 | Adjuvant (A) | 2016-01-20 | 2016-02-09 | ECX | N | N | ECX | 100343578 |
| 20163684 | 20063040 | 1.61 | 80.5 | Neo-adjuvant (N) | 2018-10-30 | 2018-11-09 | ECX | N | N | ECX | 100486937 |
| 20163690 | 20063041 | null | null | Curative (C) | 2018-08-19 | 2018-08-25 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100028821 |
| 20163695 | 20063042 | 1.64 | 93.7 | Palliative (P) | 2019-08-15 | 2019-08-21 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100328268 |
| 20163697 | 20063043 | 1.63 | 52.9 | Neo-adjuvant (N) | 2017-03-28 | 2017-04-04 | ECX | 02 | N | ECX | 100762142 |
| 20163698 | 20063044 | 1.73 | 51.8 | Neo-adjuvant (N) | 2019-06-05 | 2019-06-28 | ECX | 02 | N | ECX | 100505755 |
| 20163706 | 20063045 | 1.65 | 76.6 | Neo-adjuvant (N) | 2018-11-01 | 2018-11-01 | ECX | 2 | N | ECX | 101706617 |
| 20163710 | 20063046 | 1.71 | 74.05 | Neo-adjuvant (N) | 2019-01-25 | 2019-02-17 | ECX | 02 | N | ECX | 101493548 |
| 20163720 | 20063047 | 1.62 | 92 | Neo-adjuvant (N) | 2017-03-20 | 2017-04-10 | ECX | N | N | ECX | 100483954 |
| 20163724 | 20063048 | 1.68 | 47.6 | Palliative (P) | 2018-02-17 | 2018-03-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100031655 |
| 20163731 | 20063049 | 1.62 | 69.7 | Neo-adjuvant (N) | 2019-12-12 | 2019-12-19 | ECX | 2 | N | ECX | 100386274 |
| 20163734 | 20063050 | 1.78 | 81.7 | Palliative (P) | 2016-08-24 | 2016-08-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101385805 |
| 20163738 | 20063051 | 1.68 | 52.8 | Adjuvant (A) | 2019-11-30 | 2019-12-01 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101338495 |
| 20163740 | 20063052 | 1.58 | 68.8 | Neo-adjuvant (N) | 2019-08-23 | 2019-09-10 | ECX | 02 | N | ECX | 101008156 |
| 20163744 | 20063053 | 1.57 | 76 | Palliative (P) | 2017-04-20 | 2017-05-12 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100607271 |
| 20163755 | 20063054 | 1.54 | 57.9 | Neo-adjuvant (N) | 2018-09-07 | 2018-09-10 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100787095 |
| 20163758 | 20063055 | 1.86 | 55.8 | Neo-adjuvant (N) | 2019-12-30 | 2020-01-17 | ECX | N | N | ECX | 100963820 |
| 20163770 | 20063056 | 1.77 | 55 | Neo-adjuvant (N) | 2018-06-02 | 2018-06-04 | ECX | N | N | ECX | 100762858 |
| 20163773 | 20063057 | 1.76 | 82 | Adjuvant (A) | 2017-12-25 | 2018-01-01 | ECX | N | N | ECX | 100860296 |
| 20163776 | 20063058 | 1.7 | null | Neo-adjuvant (N) | 2017-05-20 | 2017-06-16 | Gemcitabine + Capecitabine | N | null | ECX | 100629087 |
| 20163777 | 20063059 | 1.6 | 78.2 | Neo-adjuvant (N) | 2016-10-22 | 2016-11-02 | ECX | N | N | ECX | 101170216 |
| 20163779 | 20063060 | 1.8 | 68.1 | Neo-adjuvant (N) | null | 2018-11-19 | ECX | N | N | ECX | 101266024 |
| 20163787 | 20063061 | 1.73 | 56.2 | Palliative (P) | 2017-02-27 | 2017-03-01 | ECX | N | N | ECX | 100568303 |
| 20163790 | 20063062 | 1.62 | 76.1 | Palliative (P) | 2017-11-22 | 2017-12-21 | ECX | 2 | N | ECX | 100945649 |
| 20163791 | 20063063 | 1.6 | 70.5 | Curative (C) | 2016-07-21 | 2016-07-25 | ECX | 2 | N | ECX | 100087356 |
| 20163811 | 20063064 | 1.56 | 60.9 | Adjuvant (A) | 2019-11-04 | 2019-11-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100680163 |
| 20163814 | 20063065 | 1.65 | 72.6 | Palliative (P) | 2019-09-03 | 2019-09-10 | ECX | 02 | N | ECX | 100613143 |
| 20163815 | 20063066 | 1.79 | 74 | Palliative (P) | 2016-07-20 | 2016-07-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101489340 |
| 20163818 | 20063067 | 1.81 | 69.2 | Curative (C) | 2017-10-06 | 2017-11-05 | ECX | N | null | ECX | 100147795 |
| 20163820 | 20063068 | 1.82 | 90 | Neo-adjuvant (N) | 2017-07-24 | 2017-08-07 | ECX | N | N | ECX | 101863741 |
| 20163825 | 20063069 | 1.79 | 52.3 | Neo-adjuvant (N) | 2014-07-06 | 2016-12-28 | ECX | 02 | N | ECX | 101702971 |
| 20163828 | 20063070 | 1.5 | 76.8 | Adjuvant (A) | null | 2018-04-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101446560 |
| 20163829 | 20063071 | 1.57 | 67.3 | Curative (C) | 2019-11-09 | 2019-11-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101028919 |
| 20163831 | 20063072 | 1.66 | 69 | Palliative (P) | 2017-03-01 | 2017-03-03 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100571210 |
| 20163832 | 20063073 | 1.7 | 64.55 | Palliative (P) | 2016-02-06 | 2016-02-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100891778 |
| 20163834 | 20063074 | 1.52 | 50.4 | Palliative (P) | 2018-07-10 | 2018-07-31 | ECX | 02 | N | ECX | 101311038 |
| 20163838 | 20063075 | 1.64 | 80.5 | Palliative (P) | null | 2019-08-22 | ECX | null | Y | ECX | 101014632 |
| 20163841 | 20063076 | 1.81 | 68.1 | Palliative (P) | 2019-09-10 | 2019-09-29 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101632598 |
| 20163847 | 20063077 | 1.72 | 182 | Curative (C) | 2017-08-06 | 2017-08-06 | ECX | N | N | ECX | 101206060 |
| 20163860 | 20063078 | 1.6 | 64.3 | Neo-adjuvant (N) | null | 2017-12-13 | ECX | N | N | ECX | 100387044 |